Showing results (2011-2020 of 2,042) with videos related to

Sort By:
Pageof 205
Chemosphere|October 1, 2022
Adsorptive removal of phosphate from aqueous solutions using low-cost modified biochar-packed column: Effect of operational parameters and kinetic studyT C Phuong Tran, T Phuong Nguyen, X Cuong Nguyen, et al.
Acta Neuropathologica Communications|January 6, 2016
Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeuticsLindsey M Hoffman, Mariko DeWire, Scott Ryall, et al.
Singapore Medical Journal|March 25, 2024
N-of-1 medicinePeter Wang, Qiao Ying Leong, Ni Yin Lau, et al.
AIDS (London, England)|April 26, 2022
The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in IndiaPooyan Kazemian, Delaney D Ding, Justine A Scott, et al.
Drug Design, Development and Therapy|April 17, 2023
Chemistry, Biosynthesis and Pharmacology of Streptonigrin: An Old Molecule with Future Prospects for New Drug Design, Development and TherapyNaurah Nabihah Nasir, Mahendran Sekar, Subban Ravi, et al.
Journal of Neuro-Oncology|October 9, 2020
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)Mariko DeWire, Christine Fuller, Trent R Hummel, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
hTERT Expression, Regulation, and Prognostic Significance in Pediatric MedulloblastomaRyuma Tanaka, Banlanjo Umaru, Matthew Sobo, et al.
Vaccine|November 3, 2022
Safety, tolerability and immunogenicity of Biological E's CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 studySubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Human Vaccines & Immunotherapeutics|April 28, 2023
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trialSubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Scientific Reports|July 30, 2024
Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutationsSivaprakasam T Selvavinayagam, Sathish Sankar, Yean K Yong, et al.
Pageof 205